Symbol="VYGR"
AssetType="Common Stock"
Name="Voyager Therapeutics Inc"
Description="Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1640266"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="75 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="399657000"
EBITDA="97851000"
PERatio="4.173"
PEGRatio="0"
BookValue="4.995"
DividendPerShare="0"
DividendYield="0"
EPS="2.2"
RevenuePerShareTTM="4.89"
ProfitMargin="0.519"
OperatingMarginTTM="0.49"
ReturnOnAssetsTTM="0.208"
ReturnOnEquityTTM="0.676"
RevenueTTM="190729000"
GrossProfitTTM="-19857000"
DilutedEPSTTM="2.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="227.69"
AnalystTargetPrice="13.67"
TrailingPE="4.173"
ForwardPE="-"
PriceToSalesRatioTTM="3.271"
PriceToBookRatio="2.825"
EVToRevenue="1.667"
EVToEBITDA="-8.56"
Beta="1.087"
num_52WeekHigh="14.34"
num_52WeekLow="4.77"
num_50DayMovingAverage="11.29"
num_200DayMovingAverage="8.21"
SharesOutstanding="43535600"
DividendDate="None"
ExDividendDate="None"
symbol="VYGR"
open="9.15"
high="9.22"
low="8.94"
price="9.00"
volume="279146.00"
latest_trading_day="2023-08-02"
previous_close="9.20"
change="-0.20"
change_percent="-2.1739%"
aroon_positive_momentum_days="77"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="77"
Volume_recent_avg="525319"
Change_recent_avg="0.01"
Delta_recent_avg="0.59"
Variance_recent_avg="0.3"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="77"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="1139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="621"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_positive_thumbnail_id_2="694"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
